For example, patients with cancer might have poor appetite due to cytokine inhibition of neuropeptide Y. On the other hand, supplementation with n-3 PUFAs can decrease the production of interleukin-1 and interleukin-6 cytokines, then may combat the loss of appetite in these patients [90]. Here, IL6 is linked to cancer.